Centre for Microbial Diseases and Immunity Research, Department of Microbiology and Immunology, University of British Columbia, Vancouver, Canada.
Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, Canada.
PLoS One. 2021 Apr 30;16(4):e0250977. doi: 10.1371/journal.pone.0250977. eCollection 2021.
Pseudomonas aeruginosa is a ubiquitous opportunistic pathogen that causes considerable human morbidity and mortality, particularly in nosocomial infections and individuals with cystic fibrosis. P. aeruginosa can adapt to surface growth by undergoing swarming motility, a rapid multicellular movement that occurs on viscous soft surfaces with amino acids as a nitrogen source. Here we tested the small synthetic host defense peptide, innate defense regulator 1018, and found that it inhibited swarming motility at concentrations as low as 0.75 μg/ml, well below the MIC for strain PA14 planktonic cells (64 μg/ml). A screen of the PA14 transposon insertion mutant library revealed 29 mutants that were more tolerant to peptide 1018 during swarming, five of which demonstrated significantly greater swarming than the WT in the presence of peptide. Transcriptional analysis (RNA-Seq) of cells that were inoculated on swarming plates containing 1.0 μg/ml peptide revealed differential expression of 1,190 genes compared to cells swarming on plates without peptide. Furthermore, 1018 treatment distinctly altered the gene expression profile of cells when compared to that untreated cells in the centre of the swarm colonies. Peptide-treated cells exhibited changes in the expression of genes implicated in the stringent stress response including those regulated by anr, which is involved in anaerobic adaptation, indicative of a mechanism by which 1018 might inhibit swarming motility. Overall, this study illustrates potential mechanisms by which peptide 1018 inhibits swarming surface motility, an important bacterial adaptation associated with antibiotic resistance, virulence, and dissemination of P. aeruginosa.
铜绿假单胞菌是一种普遍存在的机会性病原体,可导致相当多的人类发病率和死亡率,尤其是在医院感染和囊性纤维化患者中。铜绿假单胞菌可以通过群集运动进行表面生长,这是一种快速的多细胞运动,发生在粘性软表面上,以氨基酸作为氮源。在这里,我们测试了小分子合成宿主防御肽天然防御调节剂 1018,并发现它在低至 0.75μg/ml 的浓度下就可以抑制群集运动,远低于 PA14 浮游细胞的 MIC(64μg/ml)。对 PA14 转座子插入突变体文库的筛选显示,在群集过程中,有 29 个突变体能更好地耐受肽 1018,其中 5 个在存在肽的情况下比 WT 表现出显著更高的群集能力。对含有 1.0μg/ml 肽的群集平板上接种的细胞进行转录分析(RNA-Seq),与在没有肽的平板上群集的细胞相比,发现了 1190 个基因的差异表达。此外,与未经处理的群集菌落中心的细胞相比,1018 处理明显改变了细胞的基因表达谱。经肽处理的细胞表现出与严格应激反应相关的基因表达变化,包括那些受 anr 调节的基因,anr 参与厌氧适应,这表明了 1018 可能抑制群集运动的机制。总的来说,这项研究说明了肽 1018 抑制群集表面运动的潜在机制,群集表面运动是与铜绿假单胞菌的抗生素耐药性、毒力和传播相关的一种重要细菌适应性。